This article is excerpted from "Israel's Device Community: Finding New Models as Medtech Matures," In Vivo, October 2008. (Article number 2008800161.)
by David Cassak
Editor’s Note: The following article is excerpted from "Israel’s Device Community: Finding New Models as Medtech Matures," published in the...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Research recently published in JAMA Internal Medicine found that the FDA met its review timeline goals for the majority of breakthrough devices – but also revealed some apparent shortcomings in safety data supporting the submissions.
An interactive look at medtech and diagnostics deals made during June 2025. Data courtesy of Biomedtracker.
Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.
